BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25833694)

  • 1. Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12.
    Xie Z; Cai L; Li R; Zheng J; Wu H; Yang X; Li H; Wang Z
    Tumour Biol; 2015 Aug; 36(8):6497-505. PubMed ID: 25833694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
    Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
    Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms.
    Gagliardi A; Dugué PA; Nøst TH; Southey MC; Buchanan DD; Schmidt DF; Makalic E; Hodge AM; English DR; Doo NW; Hopper JL; Severi G; Baglietto L; Naccarati A; Tarallo S; Pace L; Krogh V; Palli D; Panico S; Sacerdote C; Tumino R; Lund E; Giles GG; Pardini B; Sandanger TM; Milne RL; Vineis P; Polidoro S; Fiorito G
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):2026-2037. PubMed ID: 32788174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers.
    Guerra SL; Maertens O; Kuzmickas R; De Raedt T; Adeyemi RO; Guild CJ; Guillemette S; Redig AJ; Chambers ES; Xu M; Tiv H; Santagata S; Jänne PA; Elledge SJ; Cichowski K
    Cancer Cell; 2020 May; 37(5):705-719.e6. PubMed ID: 32243838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis.
    Zhang Y; Zhang Y; Zeng Q; Li C; Zhou H; Liu J; Shi Z; Ma L
    J Cancer; 2022; 13(8):2620-2630. PubMed ID: 35711847
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of miR-489 targeting on SOX4 gene on proliferation and apoptosis of human hepatocellular carcinoma cells.
    Wang B; Jin WX; Zhang YL; Huang L; Ni HB; Fang D
    Afr Health Sci; 2020 Sep; 20(3):1292-1298. PubMed ID: 33402977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.
    Potter ML; Hill WD; Isales CM; Hamrick MW; Fulzele S
    Bone; 2021 Jan; 142():115679. PubMed ID: 33022453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2.
    Sun D; Li T; Xin H; An J; Yang J; Lin J; Meng X; Wang B; Ozaki T; Yu M; Zhu Y
    Oncol Lett; 2020 Oct; 20(4):8. PubMed ID: 32774482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential.
    Yang X; Zhu X; Yan Z; Li C; Zhao H; Ma L; Zhang D; Liu J; Liu Z; Du N; Ye Q; Xu X
    Mol Ther Oncolytics; 2020 Mar; 16():30-40. PubMed ID: 32258386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1.
    Zhu H; Yang J; Yang S
    Exp Ther Med; 2020 Mar; 19(3):1797-1805. PubMed ID: 32104235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in Lung Cancer Metastasis.
    Wu SG; Chang TH; Liu YN; Shih JY
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30813457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.
    Soni M; Patel Y; Markoutsa E; Jie C; Liu S; Xu P; Chen H
    Mol Cancer Res; 2018 Sep; 16(9):1348-1360. PubMed ID: 29784669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.
    Wang X; Wang X; Gu J; Zhou M; He Z; Wang X; Ferrone S
    Oncotarget; 2017 Dec; 8(69):113837-113846. PubMed ID: 29371950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs expression profile in solid and unicystic ameloblastomas.
    Setién-Olarra A; Marichalar-Mendia X; Bediaga NG; Aguirre-Echebarria P; Aguirre-Urizar JM; Mosqueda-Taylor A
    PLoS One; 2017; 12(10):e0186841. PubMed ID: 29053755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.
    Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J
    Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.
    Legras A; Pécuchet N; Imbeaud S; Pallier K; Didelot A; Roussel H; Gibault L; Fabre E; Le Pimpec-Barthes F; Laurent-Puig P; Blons H
    Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28771186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.
    Chen Y; Lu L; Feng B; Han S; Cui S; Chu X; Chen L; Wang R
    Oncotarget; 2017 May; 8(22):36787-36799. PubMed ID: 28415568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells.
    Li J; Qu W; Jiang Y; Sun Y; Cheng Y; Zou T; Du S
    Oncol Res; 2016 Oct; 24(6):391-398. PubMed ID: 28281959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.